Drug profile · INN
chlorpheniramine polistirex
CODEPREX
chlorpheniramine polistirex (CODEPREX) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — chlorpheniramine polistirex
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
chlorpheniramine polistirex (CODEPREX) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Histamine H1 receptor antagonist
Primary target: Histamine H1 receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is chlorpheniramine polistirex?
chlorpheniramine polistirex (CODEPREX) is a histamine h1 receptor antagonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for chlorpheniramine polistirex?
CODEPREX is a marketed brand name for chlorpheniramine polistirex. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of chlorpheniramine polistirex?
chlorpheniramine polistirex has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.